Vistin Pharma ASA (VISTN.OL)

Oslo Børs · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), Vistin Pharma ASA reported revenue of NOK 429.1M and net income of NOK 62.7M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

NOK	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31	FY2020 2020-12-31
Income statement
Revenue	NOK 429.1M	NOK 435.4M	NOK 287.7M	NOK 275.8M	NOK 253.2M
Operating income	NOK 85.3M	NOK 68.6M	−NOK 6.1M	NOK 33.2M	NOK 45.6M
Net income	NOK 62.7M	NOK 45.6M	−NOK 4.7M	NOK 24.9M	−NOK 97.0M
Diluted EPS	NOK 1.42	NOK 1.03	−NOK 0.11	NOK 0.56	−NOK 2.19
Cash flow
Operating cash flow	NOK 107.9M	NOK 90.6M	−NOK 10.5M	NOK 13.7M	−NOK 145.7M
Capital expenditure	NOK 40.8M	NOK 17.9M	NOK 64.3M	NOK 31.9M	NOK 53.1M
Free cash flow	NOK 67.1M	NOK 72.7M	−NOK 74.8M	−NOK 18.3M	−NOK 198.8M
Balance sheet
Cash and equivalents	NOK 12.8M	NOK 26.2M	NOK 1.4M	NOK 35.7M	NOK 77.0M
Total assets	NOK 384.9M	NOK 403.4M	NOK 407.2M	NOK 333.1M	NOK 321.9M
Total liabilities	NOK 75.4M	NOK 80.6M	NOK 133.7M	NOK 57.4M	NOK 49.5M
Total debt	–	NOK 0	–	NOK 0	–
Shareholders' equity	NOK 309.5M	NOK 322.8M	NOK 273.5M	NOK 275.8M	NOK 272.4M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in NOK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full VISTN.OL page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open VISTN.OL financials →